Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

283 (9%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

2953 (91%)

3247

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

410 (94%)

Reversed:

23 (5%)

435

483 (13%)

16 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-PROPRANOLOL 20MG TABLET Resolved 2017-08-02 2021-10-14 17976
TEVA-PROPRANOLOL 80MG TABLET Resolved 2022-06-30 2022-08-16 163906
TEVA-PROPRANOLOL 10MG TABLET Resolved 2022-06-30 2022-08-16 163903
TEVA-PROPRANOLOL 40MG TABLET Actual shortage 2026-01-08 2026-01-09 275496
TEVA-PROPRANOLOL 10MG TABLET Resolved 2025-07-18 2025-12-04 263098
TEVA-PROPRANOLOL 20MG TABLET Resolved 2022-06-03 2022-08-16 161961
TEVA-PROPRANOLOL 40MG TABLET Resolved 2021-09-02 2021-09-23 145118
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-18 2021-04-21 135974
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Actual shortage 2026-01-15 2026-01-22 276251
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-12 2019-10-04 93656
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2021-03-18 2021-04-21 135977
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-05-29 111823
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2019-09-19 2019-10-04 94375
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2020-05-01 2020-05-21 113761
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-04-10 2020-06-04 111826
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-20 2025-04-10 250906
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-16 2020-09-17 120485
TEVA-QUETIAPINE XR 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2025-08-21 2026-01-15 265779
TEVA-QUETIAPINE XR 400MG TABLET (EXTENDED-RELEASE) Resolved 2020-12-17 2021-01-21 130291
TEVA-QUETIAPINE XR 200MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-06 2025-08-14 249731
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-RASAGILINE 1MG TABLET Reversed 2025-05-28 2025-06-04 258753
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-05-28 2025-05-28 258473
TEVA-RISEDRONATE 30MG TABLET Discontinued 2025-04-29 2025-04-29 256079
TEVA-RISEDRONATE 150MG TABLET Discontinued 2021-02-12 2021-02-12 133905
TEVA-RISPERIDONE 2MG TABLET Reversed 2025-05-28 2025-06-04 258679
TEVA-RISPERIDONE 3MG TABLET Reversed 2025-05-28 2025-06-04 258685
TEVA-RISPERIDONE 1MG TABLET Reversed 2025-05-28 2025-06-04 258673
TEVA-RISPERIDONE 0.25MG TABLET Reversed 2025-05-28 2025-06-04 258711
TEVA-RISPERIDONE 4MG TABLET Reversed 2025-05-28 2025-06-04 258688
TEVA-ROSUVASTATIN 20MG TABLET Reversed 2025-05-28 2025-06-04 258765
TEVA-ROSUVASTATIN 5MG TABLET Discontinued 2022-03-25 2022-03-26 157428
TEVA-ROSUVASTATIN 10MG TABLET Discontinued 2022-03-25 2022-03-26 157431
TEVA-ROSUVASTATIN 20MG TABLET Discontinued 2022-03-25 2022-03-26 157434
TEVA-ROSUVASTATIN 40MG TABLET Discontinued 2022-03-25 2022-03-26 157437
TEVA-SPIRONOLACTONE 100MG TABLET Discontinued 2025-05-28 2025-05-28 258486
TEVA-SUCRALFATE 1G TABLET Discontinued 2025-09-02 2025-09-02 266359
TEVA-TECNAL 330MG 40MG 50MG CAPSULE Discontinued 2025-05-28 2025-05-28 258478
TEVA-TECNAL 50MG 330MG 40MG TABLET Discontinued 2025-05-28 2025-05-28 258471
TEVA-TECNAL C 1/2 50MG 330MG 30MG 40MG CAPSULE Discontinued 2025-05-28 2025-05-28 258462